SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001787306-23-000048
Filing Date
2023-05-24
Accepted
2023-05-24 17:03:07
Documents
14
Period of Report
2023-05-22
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K arqt-20230522.htm   iXBRL 8-K 36413
2 EX-99.1 prforarcutistransitionannc.htm EX-99.1 12474
6 image_0.jpg GRAPHIC 2643
  Complete submission text file 0001787306-23-000048.txt   199806

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT arqt-20230522.xsd EX-101.SCH 1887
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT arqt-20230522_lab.xml EX-101.LAB 26153
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT arqt-20230522_pre.xml EX-101.PRE 13571
8 EXTRACTED XBRL INSTANCE DOCUMENT arqt-20230522_htm.xml XML 11302
Mailing Address 3027 TOWNSGATE ROAD SUITE 300 WESTLAKE VILLAGE CA 91361
Business Address 3027 TOWNSGATE ROAD SUITE 300 WESTLAKE VILLAGE CA 91361 805-418-5006
Arcutis Biotherapeutics, Inc. (Filer) CIK: 0001787306 (see all company filings)

IRS No.: 812974255 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39186 | Film No.: 23954957
SIC: 2834 Pharmaceutical Preparations